ArticleInternational journal of surgery case reports2025
Primary bladder diffuse large B-cell lymphoma: A rare case report.
Article in International journal of surgery case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDiffuse large B-cell lymphoma (DLBCL), a common subtype of non-Hodgkin lymphoma (NHL), originates primarily from lymph nodes, with a small proportion arising extranodally in sites such as the gastrointestinal tract and central nervous system. Given the general absence of lymphoid tissue in the bladder, primary bladder DLBCL is exceptionally rare. CASE PRESENTATION: This case report describes an 83-year-old male patient with a bladder mass, initially suspected as cystitis glandularis, ultimately diagnosed via pathological examination as DLBCL. The patient underwent radical cystectomy and was subsequently scheduled for R-CHOP regimen chemotherapy. However, he succumbed to advanced disease progression one month postoperatively. CLINICAL DISCUSSION: Primary bladder diffuse large B-cell lymphoma presents with clinical symptoms clinically indistinguishable from conventional bladder urothelial carcinoma. Conventional imaging (CT/MRI) exhibit limited diagnostic utility, with definitive diagnosis requiring pathological immunohistochemical analysis. In this case, persistent hematuria necessitated radical cystectomy.
conclusionThis case highlights that bladder masses may originate from lymphoid tissue, as imaging studies may not reliably distinguish such lesions from cystitis glandularis or adenocarcinoma. Definitive diagnosis requires immunohistochemical confirmation. Bladder DLBCL management differs from conventional urothelial carcinoma protocols, necessitating postoperative R-CHOP chemotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.